Successful Treatment of Small-Cell Lung Cancer With Irinotecan in a Hemodialysis Patient With End-Stage Renal Disease
Dong Min Kim, Hyun Lee Kim, Choon Hae Chung, Chi Young Park
Korean J Intern Med. 2009;24(1):73-75.   Published online 2009 Mar 6     DOI:
Citations to this article as recorded by Crossref logo
Medical anticancer treatment of lung cancer associated with comorbidities: A review
J.P. Sculier, I. Botta, A.M. Bucalau, M. Compagnie, A. Eskenazi, R. Fischler, J. Gorham, L. Mans, L. Rozen, S. Speybrouck, X. Wang, A.P. Meert, Th. Berghmans
Lung Cancer.2015; 87(3): 241.     CrossRef
Irinotecan and temozolomide for treatment of neuroblastoma in a patient with renal failure on hemodialysis
Amy E. Armstrong, Jamie Dargart, Jennifer Reichek, David O. Walterhouse, Debora Matossian, Richard A. Cohn, Yasmin Gosiengfiao
Pediatric Blood & Cancer.2014; 61(5): 949.     CrossRef
Chemotherapy in Small Cell Lung Cancer with End-Stage Renal Disease on Hemodialysis
Sang Il Choi, Sun Seob Park, Eun Jeong Ko, Si Won Lee, Mihong Choi, Kiwon Kim
The Ewha Medical Journal.2014; 37(Suppl): S5.     CrossRef
Cancer Screening in People Who Have Chronic Disease: The Example of Kidney Disease
Germaine Wong, Kirsten Howard, Allison Tong, Jonathan C. Craig
Seminars in Dialysis.2011; 24(1): 72.     CrossRef
Concurrence of UGT1A Polymorphism and End-Stage Renal Disease Leads to Severe Toxicities of Irinotecan in a Patient with Metastatic Colon Cancer
Sung-Hao Huang, Yee Chao, Ying-Ying Wu, Jiing-Chyuan Luo, Chien-Hui Kao, Sang-Hue Yen, Chung-Pin Li
Tumori Journal.2011; 97(2): 243.     CrossRef